Vasoactive intestinal polypeptide as a biochemical marker for polymorphonuclear leukocytes

Journal of Laboratory and Clinical Medicine

Volumn 96, Issue 4, 1980, Pages 666-672

  O'Dorisio, Mary Sue ^a   O'Dorisio, Thomas M ^a   Cataland, Samuel ^a   Balcerzak, Stanley P ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

acute lymphocytic leukemia; acute myelocytic leukemia; acute myelomonocytic leukemia; ALL; AML; AMML; bovine pancreatic peptide; BPP; chronic myelocytic leukemia; CML; gastric inhibitory peptide; GIP; PMN; polymorphonuclear leukocyte; vasoactive intestinal polypeptide; VIP

Indexed keywords

VASOACTIVE INTESTINAL POLYPEPTIDE;

ACUTE MYELOBLASTIC LEUKEMIA; BLOOD AND HEMOPOIETIC SYSTEM; CANCER DIAGNOSIS; CHRONIC MYELOID LEUKEMIA; NEUTROPHIL;

ANIMAL; CHEMISTRY; GASTROINTESTINAL HORMONES; HUMAN; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID; NEUTROPHILS; RABBITS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SWINE; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0018939041     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Isolation from porcine intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon
2. Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals
3. Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance
4. Vasoactive intestinal polypeptide: neuromodulator of intestinal secretion?
5. Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors
6. Intractable watery diarrhea, ganglioneuroblastoma, and vasoactive intestinal peptide
7. Evidence for secretion of vasoactive intestinal peptide by tumors of pancreas, adrenal medulla, thyroid and lung: support for the unifying APUD concept
8. Release of vasoactive intestinal polypeptide in mast cells by histamine liberators
9. The predominant contributions of platelets to baseline and ascorbate stimulated increments in cyclic GMP in human mononuclear leukocyte preparations
10. Isolation of mononuclear cells and granulocytes from human blood
11. Characterization of glass adherent human mononuclear cells
12. Quantitative studies of phagocytosis by polymorphonuclear leukocytes. Use of paraffin oil emulsion to measure the rate of phagocytosis
13. Effect of phagocytosis on the reduced soluble sulfhydryl content of human granulocytes
14. Vasoactive intestinal peptide: quantification by radioimmunoassay in isolated cells, mucosa and muscle of hamster intestine
15. A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization
16. Surface markers on human T and B lymphocytes. I. A large population of immune lymphocytes forming nonimmune rosettes with sheep red blood cells
17. Leukemic reticuloendotheliosis: a study of the origin of the malignant cell
18. Chromosome studies in leukemia. II. Chronic granulocytic leukemia
19. Pathophysiology of VIP II
20. 131I-labelled human growth hormone of high specific activity
21. Acute leukemia: biology and treatment
22. Human lymphocyte subpopulations
23. Terminal deoxynucleotidyltransferase distribution in neoplastic and hematopoietic cells
24. Esterase reactions in acute myelomonocytic leukemia
25. The Philadelphia chromosome in human macrophages
26. Philadelphia-chromosome-positive pre-B-cell leukemia presenting as blast crisis of chronic myelogenous leukemia
27. Hematopoietic stem cell theory in relation to possible lymphoblastic conversion of chronic myeloid leukemia
28. Terminal deoxynucleotidyl transferase activities in human blood leukocytes and lymphoblast cell lines: high levels in lymphoblast cell line and in blast cells of some patients with chronic myelogenous leukemia in acute phase
29. Diagnosis and management of insulinoma
30. Immunological measurement of elevated levels of gastrin in the serum of patients with pancreatic tumors of the Zollinger-Ellison variety
31. The glucoganoma syndrome: surgically curable diabetes
32. “Somatostatinoma”: a somatostatin containing tumor of the endocrine pancreas
33. Innervation of the pancreas by vasoactive intestinal polypeptide (VIP) immunoreactive nerves
34. Vasoactive intestinal polypeptide occurs in nerve of the female genitourinary tract
35. Vasoactive intestinal polypeptide in tissues of the human female reproductive tract
36. Characterization of a vasoactive intestinal peptide sensitive adenylate cyclase in rat intestinal epithelial cells
37. Effects of synthetic vasoactive intestinal peptide (VIP), secretin and their partial sequences in gastric secretions